What pharmacologists can learn from recent advances in estrogen signalling

Trends in Pharmacological Sciences

Volumn 24, Issue 9, 2003, Pages 479-485

  Gustafsson, Jan Åke ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA ANTAGONIST; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR BETA ANTAGONIST; GENE PRODUCT; RECEPTOR BLOCKING AGENT; TAMOXIFEN; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; BRAIN; COLON CANCER; DEPRESSION; ENTERITIS; GENE FUNCTION; IMMUNE SYSTEM; LEUKEMIA; MAMMARY GLAND FUNCTION; NONHUMAN; OVARY; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE; PROSTATE DISEASE; REVIEW; SIGNAL TRANSDUCTION; UTERUS;

EID: 0041878673     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(03)00229-3     Document Type: Review

References (78)

1. Vogel C.L. Update on the current use of hormonals as therapy in advanced breast cancer. Anticancer Drugs. 14:2003;265-273.
2. Burkman R.T. Hormone replacement therapy. Current controversies. Minerva Ginecol. 55:2003;107-116.
3. Nystedt M., et al. Side effects of adjuvant endocrine treatment in premenopausal breast cancer patients: a prospective randomized study. J. Clin. Oncol. 21:2003;1836-1844.
4. Mourits M.J., et al. Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy. Br. J. Cancer. 86:2002;1546-1555.
5. Kuiper G.G., et al. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U. S. A. 93:1996;5925-5930.
6. Lubahn D.B., et al. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl. Acad. Sci. U. S. A. 90:1993;11162-11166.
7. Krege J.H., et al. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc. Natl. Acad. Sci. U. S. A. 95:1998;15677-15682.
8. Dupont S., et al. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development. 127:2000;4277-4291.
9. Couse J., Korach K.S. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr. Rev. 20:1999;358-417.
10. Nilsson S., et al. Mechanisms of estrogen action. Physiol. Rev. 81:2001;1535-1565.
11. Mitra S.W., et al. Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha. Endocrinology. 144:2003;2055-2067.
12. Nomura M., et al. Estrogen receptor-beta regulates transcript levels for oxytocin and arginine vasopressin in the hypothalamic paraventricular nucleus of male mice. Brain Res. Mol. Brain Res. 109:2002;84-94.
13. Hrabovszky E., et al. Estrogen receptor-beta immunoreactivity in luteinizing hormone-releasing hormone neurons of the rat brain. Endocrinology. 142:2001;3261-3264.
14. Witte D., et al. Estrogen receptor beta is expressed in human colorectal adenocarcinoma. Hum. Pathol. 32:2001;940-944.
15. Morales A., et al. The beta form of the estrogen receptor is predominantly expressed in the papillary cystic neoplasm of the pancreas. Pancreas. 26:2003;258-263.
16. Mollerup S., et al. Expression of estrogen receptors alpha and beta in human lung tissue and cell lines. Lung Cancer. 37:2002;153-159.
17. Naaz A., et al. Effect of ovariectomy on adipose tissue of mice in the absence of estrogen receptor alpha (ERalpha): a potential role for estrogen receptor beta (ERbeta). Horm. Metab. Res. 34:2002;758-763.
18. Stenberg A.E., et al. Estrogen receptors alpha and beta in the inner ear of the 'Turner mouse' and an estrogen receptor beta knockout mouse. Hear. Res. 166:2002;1-8.
19. Zoubina E.V., Smith P.G. Expression of estrogen receptors alpha and beta by sympathetic ganglion neurons projecting to the proximal urethra of female rats. J. Urol. 169:2003;382-385.
20. Shim G.J., et al. Disruption of the estrogen receptor {beta} gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis. Proc. Natl. Acad. Sci. U. S. A. 100:2003;6694-6699.
21. Paech K., et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science. 277:1997;1508-1510.
22. Saville B., et al. Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements. J. Biol. Chem. 275:2000;5379-5387.
23. Kushner P.J., et al. Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol. 74:2000;311-317.
24. Zou A., et al. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen. Mol. Endocrinol. 13:1999;418-430.
25. Scheidegger K.J., et al. Estradiol decreases IGF-1 and IGF-1 receptor expression in rat aortic smooth muscle cells. Mechanisms for its atheroprotective effects. J. Biol. Chem. 275:2000;38921-38928.
26. Quaedackers M.E., et al. 4-hydroxytamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER)alpha, and not through ER beta. Endocrinology. 142:2001;1156-1166.
27. Liang Y.Q., et al. Estrogen receptor beta is involved in the anorectic action of estrogen. Int. J. Obes. Relat. Metab. Disord. 26:2002;1103-1109.
28. Forster C., et al. Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium. Proc. Natl. Acad. Sci. U. S. A. 99:2002;15578-15583.
29. Bukovsky A., et al. Placental expression of estrogen receptor beta and its hormone binding variant - comparison with estrogen receptor alpha and a role for estrogen receptors in asymmetric division and differentiation of estrogen-dependent cells. Reprod. Biol. Endocrinol. 15:2003;36-57.
30. Weihua Z., et al. Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus. Proc. Natl. Acad. Sci. U. S. A. 97:2000;5936-5941.
31. Kurita T., et al. Regulation of progesterone receptors and decidualization in uterine stroma of the estrogen receptor-alpha knockout mouse. Biol. Reprod. 64:2001;272-283.
32. Wu J.J., et al. Increased expression of estrogen receptor beta in human uterine smooth muscle at term. Eur. J. Endocrinol. 142:2000;92-99.
33. Krel W., et al. Increased anxiety and synaptic plasticity in estrogen receptor-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 98:2001;12278-12282.
34. Nomura M., et al. Genotype/age interactions on aggressive behavior in gonadally intact estrogen receptor beta knockout (betaERKO) male mice. Horm. Behav. 41:2002;288-296.
35. Ogawa S., et al. Abolition of male sexual behaviors in mice lacking estrogen receptors alpha and beta (alpha beta ERKO). Proc. Natl. Acad. Sci. U. S. A. 97:2000;14737-14741.
36. Zhu Y., et al. Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science. 295:2002;505-508.
37. Somponpun S., Sladek C.D. Role of estrogen receptor-beta in regulation of vasopressin and oxytocin release in vitro. Endocrinology. 143:2002;2899-2904.
38. Wang L., et al. Estrogen receptor (ER)beta knockout mice reveal a role for ERbeta in migration of cortical neurons in the developing brain. Proc. Natl. Acad. Sci. U. S. A. 100:2003;703-708.
39. Tena-Sempere M., et al. Neonatal imprinting and regulation of estrogen receptor alpha and beta mRNA expression by estrogen in the pituitary and hypothalamus of the male rat. Neuroendocrinology. 73:2001;12-25.
40. Vinader-Caerols C., et al. Estradiol masculinizes the posteromedial cortical nucleus of the amygdala in the rat. Brain Res. Bull. 53:2000;269-273.
41. Harada N., Yamada K. Ontogeny of aromatase messenger ribonucleic acid in mouse brain: fluorometrical quantitation by polymerase chain reaction. Endocrinology. 113:1992;2306-2312.
42. Britt K.L., Findlay J.K. Estrogen actions in the ovary revisited. J. Endocrinol. 175:2002;269-276.
43. Chu S., Fuller P.J. Identification of a splice variant of the rat estrogen receptor beta gene. Mol. Cell. Endocrinol. 132:1997;195-199.
44. Petersen D.N., et al. Identification of estrogen receptor β2, a functional variant of estrogen receptor β expressed in normal rat tissues. Endocrinology. 139:1998;1082-1092.
45. Weihua Z., et al. A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc. Natl. Acad. Sci. U. S. A. 98:2001;6330-6335.
46. Cunha G.R., et al. Role of stroma in carcinogenesis of the prostate. Differentiation. 70:2002;473-485.
47. Adams J.Y., et al. Expression of estrogen receptor beta in the fetal, neonatal, and prepubertal human prostate. Prostate. 52:2002;69-81.
48. Gingrich J.R., et al. Metastatic prostate cancer in a transgenic mouse. Cancer Res. 56:1996;4096-4102.
49. Raghow S., et al. Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model. Cancer Res. 62:2002;1370-1376.
50. Mentor-Marcel R., et al. Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP). Cancer Res. 61:2001;6777-6782.
51. Medina K.L., et al. Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen. Nat. Immunol. 2:2001;718-724.
52. Kouro T., et al. Characteristics of early murine B-lymphocyte precursors and their direct sensitivity to negative regulators. Blood. 97:2001;2708-2715.
53. Jensen E.V., et al. Estrogen receptors and proliferation markers in primary and recurrent breast cancer. Proc. Natl. Acad. Sci. U. S. A. 98:2001;15197-15202.
54. Clarke R.B., et al. Estrogen sensitivity of normal human breast tissue in vivo and implanted into athymic nude mice: analysis of the relationship between estrogen-induced proliferation and progesterone receptor expression. Breast Cancer Res. Treat. 45:1997;121-133.
55. Saji S., et al. Estrogen receptors alpha and beta in the rodent mammary gland. Proc. Natl. Acad. Sci. U. S. A. 97:2000;337-342.
56. Webb P., et al. Differential SERM effects on corepressor binding dictate ERalpha activity in vivo. J. Biol. Chem. 278:2003;6912-6920.
57. Liu M.M., et al. Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression. J. Biol. Chem. 277:2002;24353-24360.
58. Cunha G.R., et al. Elucidation of a role for stromal steroid hormone receptors in mammary gland growth and development using tissue recombinants. J. Mammary Gland Biol. Neoplasia. 2:1997;393-402.
59. Lonard D.M., et al. The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation. Mol. Cell. 5:2000;939-948.
60. Fan M., et al. The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-alpha and essential for the antiproliferative activity of ICI 182,780 in ERalpha-positive breast cancer cells. Mol. Endocrinol. 17:2003;356-365.
61. Mueller S.O., et al. Mammary gland development in adult mice requires epithelial and stromal estrogen receptor alpha. Endocrinology. 143:2002;2357-2365.
62. Palmieri C., et al. Estrogen receptor beta in breast cancer. Endocr. Relat. Cancer. 9:2002;1-13.
63. Woodward T.L., et al. Fibronectin and the alpha(5)beta(1) integrin are under developmental and ovarian steroid regulation in the normal mouse mammary gland. Endocrinology. 142:2001;3214-3222.
64. Woodward T.L., et al. The role of mammary stroma in modulating the proliferative response to ovarian hormones in the normal mammary gland. J. Mammary Gland Biol. Neoplasia. 3:1998;117-131.
65. Watanabe T., et al. Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: functional difference between estrogen receptors alpha and beta. Biochem. Biophys. Res. Commun. 236:1997;140-145.
66. Saji S., et al. Clinical impact of assay of estrogen receptor beta cx in breast cancer. Breast Cancer. 9:2002;303-307.
67. Kuiper G.G., et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 138:1997;863-870.
68. Adlercreutz H. Epidemiology of phytoestrogens. Baillieres Clin. Endocrinol. Metab. 12:1998;605-623.
69. Tinwell H., et al. Estradiol-type activity of coumestrol in mature and immature ovariectomized rat uterotrophic assays. Environ. Health Perspect. 108:2000;631-634.
70. Bowe J., et al. The effects of the phytoestrogen, coumestrol, on gonadotropin-releasing hormone (GnRH) mRNA expression in GT1-7 GnRH neurones. J. Neuroendocrinol. 15:2003;105-108.
71. Boue S.M., et al. Evaluation of the estrogenic effects of legume extracts containing phytoestrogens. J. Agric. Food Chem. 51:2003;2193-2199.
72. Kousteni S., et al. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science. 298:2002;843-846.
73. Kousteni S., et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell. 104:2001;719-730.
74. Funder J.W. Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance. Annu. Rev. Med. 48:1997;231-241.
75. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science. 240:1988;889-895.
76. Jordan V.C. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents. J. Med. Chem. 46:2003;1081-1111.
77. Frasor J., et al. Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) alpha activity by ERbeta in the uterus. Endocrinology. 144:2003;3159-3166.
78. Muthyala R.S., et al. Bridged bicyclic cores containing a 1,1-diarylethylene motif are high-affinity subtype-selective ligands for the estrogen receptor. J. Med. Chem. 46:2003;1589-1602.